Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism ...

This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used ...

The company had planned to sell 13.6 million shares in the range of $28 to $31 apiece. The IPO haul was about $500 million. The biotech’s shares will trade on the Nasdaq under the stock symbol ...

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for ...

Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its development stages -- and the stock could continue to gain after that company moves ...

Insider buying A less-risky approach to biotech is to invest in large-cap biopharma stocks. These two companies saw corporate insiders recently buying stock. Pfizer Inc. (PFE): Pfizer's size and ...

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments.